In our lung cancer quiz, you’ll get to test your knowledge on the BFAST study.
What is the significance of the BFAST trial (NCT03178552)?
a. It is a study investigating whether upfront brain radiotherapy is superior to “at progression” brain radiotherapy in patients with non-small cell lung cancer (NSCLC) and asymptomatic brain metastases.
b. It is an ongoing global study evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations in circulating tumor DNA and activity of targeted therapies and immunotherapy in patients with first-line advanced NSCLC.
c. It is a study assessing the effect of molecular testing and the introduction of novel therapeutic options on the use of systemic therapy and overall survival for patients with advanced NSCLC.
d. t is a study assessing the efficacy and safety of AB928 plus carboplatin, pemetrexed, and a PD-1 antibody in patients with metastatic NSCLC.